TWD
COLL icon

True Wealth Design’s Collegium Pharmaceutical COLL Stock Holding History

True Wealth Design’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218 Hold
6
– – ﹤0.01% 2433
2026
Q1 		$199 Hold
6
– – ﹤0.01% 2334
2025
Q4 		$278 Buy
+6
New +$251 ﹤0.01% 2144
2024
Q4 		– Sell
-50
Closed -$1.93K – 1394
2024
Q3 		$1.93K Buy
+50
New +$1.78K ﹤0.01% 802

Other funds holding COLL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

True Wealth Design's COLL Position: Q2 2026 in Review

True Wealth Design held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 6 shares worth $218. The position accounts for ﹤0.01% of the portfolio, ranked #2433.

True Wealth Design first reported a position in COLL in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.93K in Q3 2024. 17 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • True Wealth Design held 6 shares of Collegium Pharmaceutical worth $218 as of Q2 2026.
  • True Wealth Design left its Collegium Pharmaceutical share count unchanged in Q2 2026.
  • Collegium Pharmaceutical made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2433 holding.
  • True Wealth Design first reported a position in Collegium Pharmaceutical in Q3 2024 and has held it in 4 quarters since.
  • True Wealth Design's Collegium Pharmaceutical position peaked at $1.93K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.